Arcus Biosciences (RCUS) Other Working Capital Changes (2017 - 2026)

Arcus Biosciences' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at $1.0 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $9.0 million (up 120.45% YoY), while the FY2025 annual figure was $8.0 million, up 114.29% from the prior year.
• Other Working Capital Changes was $1.0 million for Q1 2026 at Arcus Biosciences, down from $6.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $99.0 million in Q4 2022 to a low of -$69.0 million in Q4 2024.
• Historically, Other Working Capital Changes has averaged -$1.6 million across 5 years, with a median of $1.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes jumped 150100.0% in 2022, then slumped 3350.0% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at $99.0 million in 2022, then plunged by 102.02% to -$2.0 million in 2023, then plunged by 3350.0% to -$69.0 million in 2024, then jumped by 108.7% to $6.0 million in 2025, then sank by 83.33% to $1.0 million in 2026.
• The last three Other Working Capital Changes figures came in at $1.0 million (Q1 2026), $6.0 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.